0 NASDAQ Companies - October 31, 2024Commercial Vehicle Group Announces New Executive Appointments to Accelerate PerformanceNEW ALBANY, Ohio, Oct. 31, 2024 (GLOBE NEWSWIRE) — Commercial Vehicle Group (the “Company” or “CVG”) (NASDAQ: CVGI), a diversified […]Read More
0 NYSE Companies - October 31, 2024CubeSmart Reports Third Quarter 2024 ResultsMALVERN, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) — CubeSmart (NYSE: CUBE) today announced its operating results for the three and […]Read More
0 NASDAQ Companies - October 31, 2024Timberland Bancorp Reports Fourth Fiscal Quarter Net Income of $6.36 MillionQuarterly EPS of $0.79 and Fiscal Year EPS of $3.01 Quarterly Return on Average Assets of 1.32% Quarterly Return on […]Read More
0 NYSE Companies - October 31, 2024SiriusPoint reports eighth consecutive quarter of underwriting profits and seventh consecutive quarter of positive net incomeHAMILTON, Bermuda, Oct. 31, 2024 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT) today announced results for its […]Read More
0 NYSE Companies - October 31, 2024Ready Capital Corporation Announces Third Quarter 2024 Results and Webcast CallNEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) — Ready Capital Corporation (NYSE: RC) (the “Company”) today announced that the Company […]Read More
0 NASDAQ Companies - October 31, 2024Progress Completes Acquisition of ShareFileShareFile’s AI-powered, document-centric collaboration platform expands Progress’ industry-leading product portfolio and marks a major milestone in the company’s Total Growth Strategy […]Read More
0 NASDAQ Companies - October 31, 2024Enstar Completes Loss Portfolio Transfer With QBEHAMILTON, Bermuda, Oct. 31, 2024 (GLOBE NEWSWIRE) — Enstar Group Limited (NASDAQ: ESGR) announced today that one of its wholly-owned […]Read More
0 NASDAQ Companies - October 31, 2024Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD– Patient characteristics are consistent with other DLB studies – PURCHASE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, […]Read More